Elevance Health (ELV) Change in Accured Expenses (2010 - 2026)

Elevance Health (ELV) has reported Change in Accured Expenses for 17 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 67.75% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.7 billion (up 53.31% YoY), while the FY2025 annual figure was -$720.0 million, down 164.71% from the prior year.
• Change in Accured Expenses fell to $1.2 billion in Q2 2026 per ELV's latest filing, from $2.9 billion in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.9 billion in Q1 2026 and bottomed at -$2.3 billion in Q4 2025.
• Historically, Change in Accured Expenses has averaged $310.9 million across 5 years, with a median of $215.0 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 4679.41% — and 2024, when it slumped 1527.78%.
• Elevance Health's Change in Accured Expenses stood at $226.0 million in 2022, then plunged by 134.07% to -$77.0 million in 2023, then plunged by 1458.44% to -$1.2 billion in 2024, then plunged by 88.25% to -$2.3 billion in 2025, then soared by 154.8% to $1.2 billion in 2026.
• Business Quant data shows ELV's Change in Accured Expenses at $1.2 billion in Q2 2026, $2.9 billion in Q1 2026, and -$2.3 billion in Q4 2025.